A double-blind, comparative study in patients with gastric ulcer to evaluate the efficacy of combination use of E0671 and rabeprazole sodium.
Phase of Trial: Phase IV
Latest Information Update: 02 Nov 2018
At a glance
- Drugs Rabeprazole (Primary) ; Teprenone (Primary)
- Indications Gastric ulcer
- Focus Therapeutic Use
- Sponsors Eisai Co Ltd
- 07 Sep 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 05 Nov 2005 New trial record.